NRX Pharmaceuticals Inc (NASDAQ: NRXP) Announces the Beginning of Crisis use Exercise and Addition of Phase 2/3 Inhaled ZYESAMI™ Pilot in Georgia

July 24, 2021

NRX Pharmaceuticals Inc (NASDAQ: NRXP) announced it is starting scientific training of Nation of Georgia (Georgia) ICU doctors in the use of circulatory ZYESAMI™ for crisis use in patients suffering from Acute COVID-19, and gasped ZYESAMI™ for usage in phase 2/3 scientific trials, for patients in sorrow with COVID-19. NRx lengthens its unending Phase 2/3 pilot of gasped ZYESAMI™ to Georgia NRx also announced that the continuing stage 2/3 pilot…